Cargando…

Elderly‐onset systemic Epstein–Barr virus‐positive T‐cell lymphoma of childhood

Detalles Bibliográficos
Autores principales:	Nishikubo, Masashi, Hiramoto, Nobuhiro, Yamashita, Daisuke, Imoto, Hiroharu, Sato, Yoshitaka, Okuno, Yusuke, Haga, Hironori, Nannya, Yasuhito, Ogawa, Seishi, Kimura, Hiroshi, Ishikawa, Takayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542217/ https://www.ncbi.nlm.nih.gov/pubmed/35611496 http://dx.doi.org/10.1111/pin.13231

Ejemplares similares

Coincidence of cutaneous blastic plasmacytoid dendritic cell neoplasm and myelodysplastic syndrome derived from clonal hematopoiesis
por: Yamada, Tomohiko, et al.
Publicado: (2023)

Deletion of Viral microRNAs in the Oncogenesis of Epstein–Barr Virus-Associated Lymphoma
por: Kimura, Hiroshi, et al.
Publicado: (2021)

Regulation of Epstein-Barr Virus Life Cycle and Cell Proliferation by Histone H3K27 Methyltransferase EZH2 in Akata Cells
por: Ichikawa, Takaya, et al.
Publicado: (2018)

Role of Epstein–Barr Virus C Promoter Deletion in Diffuse Large B Cell Lymphoma
por: Mabuchi, Seiyo, et al.
Publicado: (2021)

Epstein-Barr Virus BBRF2 Is Required for Maximum Infectivity
por: Masud, H. M. Abdullah Al, et al.
Publicado: (2019)

Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation
por: Murata, Takayuki, et al.
Publicado: (2021)

Reversible renal-limited thrombotic microangiopathy due to gemcitabine-dexamethasone-cisplatin therapy: a case report
por: Nishikubo, Masashi, et al.
Publicado: (2021)

Initial Characterization of the Epstein–Barr Virus BSRF1 Gene Product
por: Yanagi, Yusuke, et al.
Publicado: (2019)

Viral loads correlate with upregulation of PD-L1 and worse patient prognosis in Epstein–Barr Virus-associated gastric carcinoma
por: Nakayama, Atsuhito, et al.
Publicado: (2019)

Exosomes of Epstein-Barr Virus-Associated Gastric Carcinoma Suppress Dendritic Cell Maturation
por: Hinata, Munetoshi, et al.
Publicado: (2020)

Epstein-Barr virus infection-induced inflammasome activation in human monocytes
por: Torii, Yuka, et al.
Publicado: (2017)

PB1862: VENETOCLAX AND AZACITIDINE THERAPY IN ACUTE MYELOID LEUKEMIA PATIENTS WITH SEVERE RENAL IMPAIRMENT
por: Naka, Ryosuke, et al.
Publicado: (2023)

Direct Evidence of Abortive Lytic Infection-Mediated Establishment of Epstein-Barr Virus Latency During B-Cell Infection
por: Inagaki, Tomoki, et al.
Publicado: (2021)

Growth Transformation of B Cells by Epstein-Barr Virus Requires IMPDH2 Induction and Nucleolar Hypertrophy
por: Sugimoto, Atsuko, et al.
Publicado: (2023)

Complete Bone Marrow Necrosis with Charcot-Leyden Crystals Caused by Myeloid Neoplasm with Mutated NPM1 and TET2
por: Saito, Kenki, et al.
Publicado: (2022)

Clinical utility of circulating cell-free Epstein–Barr virus DNA in patients with gastric cancer
por: Shoda, Katsutoshi, et al.
Publicado: (2017)

Epstein–Barr virus tegument protein BGLF2 in exosomes released from virus-producing cells facilitates de novo infection
por: Sato, Yoshitaka, et al.
Publicado: (2022)

Epstein-Barr Virus BBLF1 Mediates Secretory Vesicle Transport to Facilitate Mature Virion Release
por: Uddin, Md Kamal, et al.
Publicado: (2023)

Epstein-Barr virus gastric ulcer associated with ruxolitinib
por: Kusano, Yoshiharu, et al.
Publicado: (2016)

Antitumor activity of cyclin‐dependent kinase inhibitor alsterpaullone in Epstein‐Barr virus‐associated lymphoproliferative disorders
por: Watanabe, Takahiro, et al.
Publicado: (2019)

The Epstein-Barr Virus BRRF1 Gene Is Dispensable for Viral Replication in HEK293 cells and Transformation
por: Yoshida, Masahiro, et al.
Publicado: (2017)

P424: LANDSCAPE OF CHROMATIN ACCESSIBILITY IN ACUTE MYELOID LEUKEMIA
por: Ochi, Yotaro, et al.
Publicado: (2023)

Humoral response and safety of the BNT162b2 and mRNA-1273 COVID-19 vaccines in allogeneic hematopoietic stem cell transplant recipients: An observational study
por: Nishikubo, Masashi, et al.
Publicado: (2023)

Humoral and cellular responses after COVID-19 booster vaccination in patients recently treated with anti-CD20 antibodies
por: Nishikubo, Masashi, et al.
Publicado: (2023)

Antitumor effects of duvelisib on Epstein–Barr virus‐associated lymphoma cells
por: Kawada, Jun‐ichi, et al.
Publicado: (2018)

Venetoclax-Azacitidine Bridging PTCy-haplo-PBSCT for Refractory Acute Myeloid Leukemia with IDH2 Mutations
por: Daido, Yusuke, et al.
Publicado: (2023)

Characterization of a Suppressive Cis-acting Element in the Epstein–Barr Virus LMP1 Promoter
por: Yoshida, Masahiro, et al.
Publicado: (2017)

Epstein-Barr Virus in Gastric Carcinoma
por: Nishikawa, Jun, et al.
Publicado: (2014)

Chronic Active Epstein–Barr Virus Disease
por: Kimura, Hiroshi, et al.
Publicado: (2017)

BGLF2 Increases Infectivity of Epstein-Barr Virus by Activating AP-1 upon De Novo Infection
por: Konishi, Natsuno, et al.
Publicado: (2018)

Epstein-Barr Virus (EBV)-associated Gastric Carcinoma
por: Iizasa, Hisashi, et al.
Publicado: (2012)

Epstein-Barr virus: the molecular virology and the associated diseases
por: Murata, Takayuki
Publicado: (2023)

The Role of Epigenetic Regulation in Epstein-Barr Virus-Associated Gastric Cancer
por: Nishikawa, Jun, et al.
Publicado: (2017)

The C-Terminus of Epstein-Barr Virus BRRF2 Is Required for its Proper Localization and Efficient Virus Production
por: Watanabe, Takahiro, et al.
Publicado: (2017)

The Role of Transforming Growth Factor β in Cell-to-Cell Contact-Mediated Epstein-Barr Virus Transmission
por: Nanbo, Asuka, et al.
Publicado: (2018)

Epstein-Barr Virus Dacryoadenitis in a Young Woman
por: Watanabe, Tamami, et al.
Publicado: (2022)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Role of latent membrane protein 1 in chronic active Epstein–Barr virus infection-derived T/NK-cell proliferation
por: Ito, Takuto, et al.
Publicado: (2014)

Epstein–Barr Virus Infection of Oral Squamous Cells
por: Heawchaiyaphum, Chukkris, et al.
Publicado: (2020)

A Herpesvirus Specific Motif of Epstein-Barr Virus DNA Polymerase Is Required for the Efficient Lytic Genome Synthesis
por: Narita, Yohei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qj26bff4oubpoogtbhtgmodfj4